A team of doctors and scientists have found "clear evidence" of a cause of neurodegeneration in people with Alzheimer’s disease."Changes in the orchestration of brain oxygenation dynamics and neuronal ...

MALVERN, PA - Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company focused on neurodegenerative diseases, has successfully closed its public offering, generating $21 million in gross ...